[Regulatory] state board actions worth reading if you use a compounder
503B. That is the whole post, but I will justify it. Everything else people worry about in c/coldchain is downstream of it. Titration speed, early fullness, the endless dose arguments — most of it resolves if you sort 503B out first, and almost nobody does. I say this having got it wrong for 10 months. My A1c was the…
Mechanistically the bit that matters is 503A. It explains most of the early profile and a decent chunk of the outcome.
Disagree but this is the good kind of wrong — it is specific enough to be checked.
Asked 19 compounders about API source. One told me, one dodged, one said they cannot say. The answer is the signal.
The 503A pharmacy I used lost their shortage list eligibility. Same day, compounding became illegal. Rules are real.
API transparency is the question that separates good compounders from sketchy ones